High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis

Taro Iwamoto; Jessica M. Dorschner; Shanmugapriya Selvaraj; Valeria Mezzano; Mark A. Jensen; Danielle Vsetecka; Shreyasee Amin; Ashima Makol; Thomas Osborn; Kevin Moder; Vaidehi R. Chowdhary; Peter Izmirly; H. Michael Belmont; Robert M. Clancy; Jill P. Buyon; Ming Wu; Cynthia A. Loomis; Timothy B. Niewold

doi:10.3899/jrheum.210391

Research ArticleSystemic Lupus Erythematosus

High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis

Taro Iwamoto, Jessica M. Dorschner, Shanmugapriya Selvaraj, Valeria Mezzano, Mark A. Jensen, Danielle Vsetecka, Shreyasee Amin, Ashima Makol, Thomas Osborn, Kevin Moder, Vaidehi R. Chowdhary, Peter Izmirly, H. Michael Belmont, Robert M. Clancy, Jill P. Buyon, Ming Wu, Cynthia A. Loomis and Timothy B. Niewold

The Journal of Rheumatology April 2022, 49 (4) 388-397; DOI: https://doi.org/10.3899/jrheum.210391

Taro Iwamoto

1T. Iwamoto, MD, PhD, Colton Center for Autoimmunity, New York University, New York, New York, USA, and Allergy and Clinical Immunology, Chiba University, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Taro Iwamoto

Jessica M. Dorschner

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shanmugapriya Selvaraj

3S. Selvaraj, MS, V. Mezzano, MD, PhD, M. Wu, MD, C.A. Loomis, MD, PhD, Department of Pathology, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valeria Mezzano

3S. Selvaraj, MS, V. Mezzano, MD, PhD, M. Wu, MD, C.A. Loomis, MD, PhD, Department of Pathology, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark A. Jensen

4M.A. Jensen, PhD, R.M. Clancy, PhD, J.P. Buyon, MD, T.B. Niewold, MD, Colton Center for Autoimmunity, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Danielle Vsetecka

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shreyasee Amin

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ashima Makol

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Osborn

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kevin Moder

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vaidehi R. Chowdhary

2J.M. Dorschner, BS, D. Vsetecka, MPH, S. Amin, MD, A. Makol, MD, T. Osborn, MD, K. Moder, MD, V.R. Chowdhary, MD, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Izmirly

5P. Izmirly, MD, H.M. Belmont, MD, Division of Rheumatology, New York University, New York, New York, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H. Michael Belmont

5P. Izmirly, MD, H.M. Belmont, MD, Division of Rheumatology, New York University, New York, New York, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert M. Clancy

4M.A. Jensen, PhD, R.M. Clancy, PhD, J.P. Buyon, MD, T.B. Niewold, MD, Colton Center for Autoimmunity, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jill P. Buyon

4M.A. Jensen, PhD, R.M. Clancy, PhD, J.P. Buyon, MD, T.B. Niewold, MD, Colton Center for Autoimmunity, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ming Wu

3S. Selvaraj, MS, V. Mezzano, MD, PhD, M. Wu, MD, C.A. Loomis, MD, PhD, Department of Pathology, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cynthia A. Loomis

3S. Selvaraj, MS, V. Mezzano, MD, PhD, M. Wu, MD, C.A. Loomis, MD, PhD, Department of Pathology, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Timothy B. Niewold

4M.A. Jensen, PhD, R.M. Clancy, PhD, J.P. Buyon, MD, T.B. Niewold, MD, Colton Center for Autoimmunity, New York University, New York, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Timothy.Niewold@nyulangone.org

Article
Figures & Data
Supplemental
References
Info & Metrics
PDF
eLetters

PreviousNext

Published eLetters

eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.

If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 49, Issue 4

1 Apr 2022

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis